Page last updated: 2024-12-05

cyanuric chloride

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Cyanuric chloride, also known as 2,4,6-trichloro-1,3,5-triazine, is a highly reactive and versatile chemical compound used in a wide range of industrial applications. It is a colorless, crystalline solid with a pungent odor. Cyanuric chloride is synthesized through the chlorination of cyanuric acid. It is a key precursor for the production of many important chemicals, including herbicides, dyes, pharmaceuticals, and flame retardants. The compound is also used in the production of resins, polymers, and other materials. Cyanuric chloride is highly reactive and can undergo a variety of chemical reactions, including hydrolysis, amination, and alkylation. Due to its reactivity, cyanuric chloride is often used as a building block for the synthesis of complex molecules. Its importance lies in its wide range of applications and its ability to serve as a precursor for various industrially important chemicals. The study of cyanuric chloride focuses on its synthesis, reactivity, applications, and environmental impact. Research efforts are ongoing to explore new and sustainable methods for the synthesis of cyanuric chloride and to develop safer and more environmentally friendly applications for this versatile compound.'

cyanuric chloride : A chloro-1,3,5-triazine in which the triazine ring is substituted on each carbon by chlorine. Its main use is in the preparation of the triazine-class pesticides. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID7954
CHEMBL ID1530777
CHEBI ID58964
SCHEMBL ID20781
MeSH IDM0071677

Synonyms (89)

Synonym
2,4,6-trichloro-sym-triazine
CHEBI:58964 ,
wln: t6n cn enj bg dg fg
nsc3512
s-triazine trichloride
tricyanogen chloride
syn-trichlotriazin
2,6-trichloro-1,3,5-triazine
1,5-triazine, 2,4,6-trichloro-
2,6-trichlorotriazine
cyanuric trichloride
cyanuric acid chloride
s-trichlorotriazine
2,6-trichloro-s-triazine
trichlorocyanidine
1,5-trichlorotriazine
nsc-3512
s-triazine,4,6-trichloro-
trichloro-s-triazine
chlorotriazine
cyanur chloride
kyanurchlorid
108-77-0
cyanuryl chloride
cyanuric chloride
1,3,5-triazine, 2,4,6-trichloro-
s-triazine, 2,4,6-trichloro-
NCGC00090920-01
2,4,6-trichloro-1,3,5-triazine
cyanuric chloride, 99%
NCGC00090920-02
ai3-17788
cyanurchloride
2,4,6-trichloro-s-triazine
hsdb 2905
un2670
syn-trichlotriazin [czech]
kyanurchlorid [czech]
brn 0124246
cyanuric acid trichloride
einecs 203-614-9
nsc 3512
tricholorotriazine
sym-trichlorotriazine
AKOS000120158
2,4,6-tris(chloranyl)-1,3,5-triazine
A801923
NCGC00090920-03
cyanuric chloride [un2670] [corrosive]
5u4l4qhd6i ,
ec 203-614-9
5-26-01-00311 (beilstein handbook reference)
unii-5u4l4qhd6i
dtxsid6026799 ,
tox21_303286
cas-108-77-0
NCGC00257057-01
dtxcid306799
NCGC00259998-01
tox21_202449
STL163964
BBL013185
FT-0624144
EPITOPE ID:119708
SCHEMBL20781
2,4,6-trichloro-s-triazine [hsdb]
cyanuric chloride [mi]
trichloro-1,3,5-triazine
2,4,6-trichloro-[1,3,5]triazine
cyanurylchloride
2,4,6-trichloro-[1,3,5]-triazine
2,4,6-trichloro[1,3,5]triazine
cyan uric chloride
W-108714
CHEMBL1530777
2,4,6-trichloro-(1,3,5)-triazine
2,4,6-trichlor-(1,3,5)triazine
1,3,5-trichloro-2,4,6-triazine
un 2670
mfcd00006046
cyanuric chloride, lonza quality, >=99.5% (w/w)
P20007
CS-B1794
Q419742
EN300-19116
HMS3749M17
cyanuric-13c3 chloride 99 atom % 13c
BP-31200
Z104472828

Research Excerpts

Effects

ExcerptReferenceRelevance
"Cyanuric chloride has been found to be an efficient catalyst for the synthesis of 2,3-unsaturated O-glycosides from the reaction of 3,4,6-tri-O-acetyl-D-glucal and a wide range of alcohols in dichloromethane at room temperature. "( Cyanuric chloride as an efficient catalyst for the synthesis of 2,3-unsaturated O-glycosides by Ferrier rearrangement.
Li, N; Yang, X, 2014
)
3.29

Treatment

ExcerptReferenceRelevance
"Treatment of cyanuric chloride with chiral amines or esters of chiral amino acids gave chiral 2,4-dichloro-6-alkylamino-1,3,5-triazines (2-5) in 49-69% yield, which were found useful as coupling reagents. "( Synthesis and application of chiral triazine condensing reagents prepared from esters of amino acids.
Jastrzabek, K; KamiƄski, ZJ; Zajac, KJ, 2001
)
0.68
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
cross-linking reagentA reagent with two reactive groups, usually at opposite ends of the molecule, that are capable of reacting with and thereby forming bridges between macromolecules, principally side chains of amino acids in proteins, allowing the locations of naturally reactive areas within the proteins to be identified.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
organochlorine compoundAn organochlorine compound is a compound containing at least one carbon-chlorine bond.
chloro-1,3,5-triazineA member of the class of 1,3,5-triazines that is 1,3,5-triazine substituted by at least one chloro group at unspecified position.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (20)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
LuciferasePhotinus pyralis (common eastern firefly)Potency65.12600.007215.758889.3584AID1224835
15-lipoxygenase, partialHomo sapiens (human)Potency31.62280.012610.691788.5700AID887
RAR-related orphan receptor gammaMus musculus (house mouse)Potency68.58960.006038.004119,952.5996AID1159521
GLI family zinc finger 3Homo sapiens (human)Potency15.09020.000714.592883.7951AID1259369
AR proteinHomo sapiens (human)Potency0.02680.000221.22318,912.5098AID1259243
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency2.23870.011212.4002100.0000AID1030
thyroid stimulating hormone receptorHomo sapiens (human)Potency12.58930.001318.074339.8107AID926; AID938
estrogen receptor 2 (ER beta)Homo sapiens (human)Potency21.70310.000657.913322,387.1992AID1259377; AID1259394
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency3.44940.001530.607315,848.9004AID1224841; AID1259401
pregnane X nuclear receptorHomo sapiens (human)Potency35.48130.005428.02631,258.9301AID720659
estrogen nuclear receptor alphaHomo sapiens (human)Potency27.69170.000229.305416,493.5996AID743075
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency50.11870.001019.414170.9645AID588537
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency76.95880.001723.839378.1014AID743083
thyroid stimulating hormone receptorHomo sapiens (human)Potency68.58960.001628.015177.1139AID1259385
activating transcription factor 6Homo sapiens (human)Potency0.00120.143427.612159.8106AID1159516
Caspase-7Cricetulus griseus (Chinese hamster)Potency75.63030.006723.496068.5896AID1346980
thyroid hormone receptor beta isoform aHomo sapiens (human)Potency0.00340.010039.53711,122.0200AID588545; AID588547
caspase-3Cricetulus griseus (Chinese hamster)Potency75.63030.006723.496068.5896AID1346980
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency62.94170.000323.4451159.6830AID743065; AID743067
heat shock protein beta-1Homo sapiens (human)Potency61.65240.042027.378961.6448AID743210; AID743228
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (117)

TimeframeStudies, This Drug (%)All Drugs %
pre-199023 (19.66)18.7374
1990's17 (14.53)18.2507
2000's21 (17.95)29.6817
2010's51 (43.59)24.3611
2020's5 (4.27)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 50.17

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index50.17 (24.57)
Research Supply Index4.84 (2.92)
Research Growth Index4.80 (4.65)
Search Engine Demand Index78.91 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (50.17)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (1.59%)6.00%
Case Studies2 (1.59%)4.05%
Observational0 (0.00%)0.25%
Other122 (96.83%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]